Opiant Pharmaceuticals Inc (OPNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 10-2017 | 09-2017 | 07-2017 | 06-2017 | 04-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,633 | -5,967 | N/A | -2,558 | 6,920 |
| Depreciation Amortization | 1 | 5 | N/A | 3 | 4 |
| Accounts receivable | 3,750 | N/A | N/A | -3,750 | 313 |
| Accounts payable and accrued liabilities | 685 | 1,198 | N/A | 980 | 1,250 |
| Other Working Capital | 3,417 | -2,033 | N/A | -4,128 | 132 |
| Other Operating Activity | -3,190 | 351 | 0 | 3,848 | -254 |
| Operating Cash Flow | $-970 | $-6,446 | $N/A | $-5,605 | $8,364 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 0 | 0 | 0 | 0 | -165 |
| Financing Cash Flow | $N/A | $N/A | $N/A | $N/A | $-165 |
| Beginning Cash Position | 6,873 | 13,200 | N/A | 13,200 | 1,481 |
| End Cash Position | 5,903 | 6,754 | N/A | 7,595 | 9,681 |
| Net Cash Flow | $-970 | $-6,446 | $N/A | $-5,605 | $8,199 |
| Free Cash Flow | |||||
| Operating Cash Flow | -970 | -6,446 | N/A | -5,605 | 8,364 |
| Free Cash Flow | -970 | -6,446 | 0 | -5,605 | 8,364 |